The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure

计划入组 80 人 · 首次发布于 2024 年 8 月 30 日

The CONFORM Pivotal Trial

计划入组 1,600 人 · 首次发布于 2021 年 12 月 7 日

EchoTip AcuCore Post-Market Clinical Study

计划入组 183 人 · 首次发布于 2024 年 4 月 10 日

selective class IIa HDAC inhibitor (ASINEX)

class 1 HDAC inhibitors (unspecified indication)

HDAC Class I Inhibitor(Italfarmaco SpA)

GLOBAL X GOLD ETF CLASS A SHS

HAMILTON CAPITAL PARTNERS INC CANADIAN EQTY YIELD MAXIMIZE CLASS E ETF

United States

Conformal Medical Initiates GLACE Study for Next-Gen LAAO Device with ICE Imaging

AcuCort Reaches FDA Agreement on Pediatric Study Plan for Zeqmelit®, Clearing Path Toward US NDA Submission

FDA Approves Sunlenca (Lenacapavir), a First-in-Class HIV-1 Capsid Inhibitor